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Molecular basis for the binding and selective
dephosphorylation of Na+/H+ exchanger 1
by calcineurin
Ruth Hendus-Altenburger 1,5, Xinru Wang 2,3,5, Lise M. Sjøgaard-Frich4, Elena Pedraz-Cuesta4,
Sarah R. Sheftic2, Anne H. Bendsøe1,4, Rebecca Page2, Birthe B. Kragelund 1, Stine F. Pedersen 4 &
Wolfgang Peti 2
Very little is known about how Ser/Thr protein phosphatases speciﬁcally recruit and
dephosphorylate substrates. Here, we identify how the Na+/H+-exchanger 1 (NHE1), a key
regulator of cellular pH homeostasis, is regulated by the Ser/Thr phosphatase calcineurin
(CN). NHE1 activity is increased by phosphorylation of NHE1 residue T779, which is speci-
ﬁcally dephosphorylated by CN. While it is known that Ser/Thr protein phosphatases prefer
pThr over pSer, we show that this preference is not key to this exquisite CN selectivity. Rather
a combination of molecular mechanisms, including recognition motifs, dynamic charge-
charge interactions and a substrate interaction pocket lead to selective dephosphorylation of
pT779. Our data identify T779 as a site regulating NHE1-mediated cellular acid extrusion and
provides a molecular understanding of NHE1 substrate selection by CN, speciﬁcally, and how
phosphatases recruit speciﬁc substrates, generally.
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The plasma membrane Na
+/H+ exchanger 1 (NHE1,
SLC9A1) is a central regulator of cellular pH and volume,
and thus is important for cell proliferation, survival, and
motility in mammalian tissues. As a consequence, its dysregula-
tion leads to disease, especially cancer and cardiovascular dis-
orders1–3. NHE1 comprises a 12 transmembrane-helix domain
that mediates Na+/H+ exchange and a C-terminal intracellular
domain that is heavily phosphorylated and functions as a protein:
protein interaction hub. Critically, these modiﬁcations and
interactions control NHE1 activity. The C-terminal ~135 residues
of NHE1 (NHE1ct; residues I680-Q815) is an intrinsically dis-
ordered region (IDR) that contains most of the identiﬁed NHE1
phosphorylation sites4,5.
Ser/Thr kinases use protein:protein interactions and sequence-
speciﬁc recognition sequences to identify and phosphorylate their
substrates; indeed, for this reason >10,000 kinase phosphorylation
sites have been identiﬁed, allowing the functional importance of
these sites to be readily investigated. Multiple mechanisms regulate
NHE1 activity including increases in the free, intracellular Ca2+
concentration ([Ca2+]i)6,7, and phosphorylation by the MAP
kinases ERK1/2, p38, and c-Jun N-terminal kinase (JNK)8–10.
We recently discovered that ERK2-mediated NHE1 phosphoryla-
tion is achieved, in part, via direct binding between ERK2 and
the NHE1ct, resulting in ERK2-mediated phosphorylation of six
Ser/Thr residues that conform to the ERK2 recognition sequence:
[S/T]P11.
Much less is known about the speciﬁcity controlling the
reversing dephosphorylation reactions, which is reﬂected by the
fact that only ~400 phosphatase:substrate pairs are currently
known. This is due, in part, to an apparent lack of phosphatase-
speciﬁc recognition sequences, making it impossible to use
bioinformatics to understand the substrate:enzyme relationship12.
NHE1 interacts with, and is likely regulated by, protein phos-
phatase 113 and 2A14 and the Tyr phosphatase SHP215. A direct
interaction of NHE1 with calcineurin (CN, protein phosphatase
2B or PP3) was also demonstrated16. However, if NHE1 is a direct
substrate of any of these phosphatases, which residues are
dephosphorylated and if this regulation has consequences for
NHE1 function is still unknown.
CN is a ubiquitously expressed Ca2+-dependent Ser/Thr
phosphatase17. It regulates multiple physiological processes
including development, cardiac function, and the immune
response18. CN is a heterodimer composed of calcineurin A
(CNA) and B (CNB), where CNA can be further divided into four
functional domains: the catalytic domain, the CNB-binding
domain, a calmodulin (CaM)-binding domain, and an auto-
inhibitory domain (AID), which blocks the CN active site19,20.
Upon an increase in [Ca2+]i, both CNB and CaM become Ca2+-
loaded, ultimately displacing the AID from the catalytic site,
stimulating phosphatase activity. However, how CN recognizes its
substrates is only poorly understood.
Recently, it was shown that CN recruits regulators, inhibi-
tors, and substrates using two short linear motifs (SLiMs), the
PxIxIT and the LxVP motifs12,21. These SLiMs are typically
found in intrinsically disordered proteins/regions (IDPs/IDRs),
and bind to the corresponding PxIxIT and LxVP-binding
pockets in CN. The PxIxIT motif binds the catalytic domain of
CNA22, whereas the LxVP motif binds to a hydrophobic cleft at
the interface of the CNA and CNB subunits21. In contrast to the
PxIxIT-binding pocket, the binding cleft for the LxVP motif is
only accessible in the active conformation of CN23. The inter-
action between NHE1 and CN was shown to depend on a
PxIxIT motif in the NHE1ct16. However, it is not known if
NHE1ct also has an LxVP motif. Further, if and how these
motifs inﬂuence substrate recognition and speciﬁcity, or if there
are other features that deﬁne substrate speciﬁcity is currently
unknown for CN speciﬁcally and for Ser/Thr phosphatases
generally.
Here, we integrate multiple complementary molecular and
cellular experiments to show how CN is recruited to NHE1.
Furthermore, we identify an NHE1 phosphorylation site, T779,
that is critical for regulating NHE1 transport activity. Further, we
show that CN speciﬁcally dephosphorylates pT779 to return
NHE1 activity to basal levels. Finally, using molecular and cellular
experiments, we deﬁne the key interactions that generate this CN
selectivity at the CN active site. Together, these data not only
reveal a key role for phosphatases in controlling NHE1 activity,
but also provide molecular insights into the multiple mechanisms
used by CN to achieve substrate speciﬁcity.
Results
NHE1 binds CN using a PxIxIT and an LxVP motif. NHE1
was previously shown to bind CN using a PxIxIT motif,
715PVITID720 16. This sequence is present in the intrinsically
disordered C-terminal tail of NHE1 (residues I680-Q815, here-
after referred to as NHE1ct; Fig. 1a; variants used in this study are
summarized in Supplementary Fig. 1; CN overview is summar-
ized in Fig. 1b)5. An alignment of 15 diverse NHE1ct sequences
from multiple species revealed the presence of a putative LxVP
motif, 684LTVP687 (human) ~30 amino acids N-terminal to the
PxIxIT motif (Fig. 1c). Further, the alignment showed that the
LxVP motif is considerably more conserved than the PxIxIT
motif, supporting its potential importance in CN binding and
NHE1 function.
To test if the putative LxVP motif in NHE1 (684LTVP687) binds
directly to CN, we used NMR spectroscopy. An overlay of the 2D
[1H,15N] HSQC spectrum of 15N-labeled NHE1ct in the presence
and absence of CN showed that multiple peaks disappeared upon
complex formation (Fig. 2a). Speciﬁcally, cross-peaks correspond-
ing to NHE1 residues 684LTVP687 (L684, T685, V686) and
715PVITID720 (I717, I719) were signiﬁcantly broadened partially
beyond detection upon binding CN. In addition, many of the
peaks originating from the 27 residues that connect the NHE1
LxVP and PxIxIT motifs were also broadened upon complex
formation (Fig. 2a, b), indicating either that this region is
involved in the interaction with CN or that the conformational
freedom of the linker is impaired by the anchoring of both SLiMs
to CN24,25. Thus, NHE1 684LTVP687 is a CN-speciﬁc LxVP SLiM
that, together with NHE1 715PVITID720, binds to CN.
To determine the contribution of each SLiM to CN binding, we
used isothermal titration calorimetry (ITC; Table 1). CN and
NHE1ct formed a tight 1:1 complex (KD= 59 ± 9 nM; Fig. 2c).
Mutating either the NHE1 LxVP (NHE1ctATAP) or PxIxIT
(NHE1ctAVATAA) motifs resulted in a signiﬁcant reduction in
binding afﬁnity (Fig. 2d, e). Speciﬁcally, NHE1ctATAP bound CN
with a KD of 4.8 ± 0.5 µM (~80-fold reduction vs. WT), while
NHE1ctAVATAA bound CN with a KD of 2.4 ± 0.5 µM (~40-fold
reduction vs. WT). Similarly, short NHE1 LxVP and PxIxIT
peptides bound CN with KD values of 4.3 ± 0.5 and 6.5 ± 0.5 µM,
respectively (Fig. 2f, g). The increase in the KD for the
NHE1 peptides versus the corresponding binding compromised
variant (NHE1ctATAP includes only a functional PxIxIT site;
NHE1ctAVATAA includes only a functional LxVP site) suggests a
contribution by the linker and/or distal residues to the overall
binding afﬁnity. Finally, the large increase in afﬁnity observed for
NHE1ct compared to the afﬁnities of each peptide or NHE1ct
motif variants demonstrates avidity.
NHE1:CN interaction in cells. To determine if both the LxVP
and PxIxIT motifs are important for NHE1:CN binding in cells,
we stably expressed either full-length NHE1WT, NHE1ATAP,
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NHE1AVATAA, or NHE1AVATAA/ATAP in PS120 mammalian ﬁbro-
blasts (Fig. 2h, Supplementary Fig. 2; these cells lack endogenous
NHE1). As expected from in situ proximity ligation assays
(PLA), which conﬁrmed the close proximity (<40 nm) of endo-
genous NHE1 with endogenous CN in MCF-7 breast cancer cells
(Fig. 2i, j), stably expressed WT NHE1 robustly co-
immunoprecipitated with CN in PS120 cells, with and without an
increase in cellular [Ca2+]i (Fig. 2h, Supplementary Fig. 2). Similar
amounts of NHE1 co-immunoprecipitated with CN for the variants
NHE1ATAP and NHE1AVATAA, whereas NHE1AVATAA/ATAP
co-immunoprecipitated less with CN than WT NHE1. These data
together with our NMR and ITC data (Fig. 2a–g) demonstrate
that both the NHE1 LxVP and PxIxIT motifs contribute to CN
binding.
Sequence differences in CN-binding motifs ﬁne-tune CN
binding. To understand how NHE1 binds CN at a molecular
level, we used ITC and X-ray crystallography (Fig. 3a, b). First, we
used ITC to show that NHE1 residues I680-S723 constitute the
minimal NHE1 CN-binding domain (NHE1 residues I680-S723,
hereafter referred to as NHE1ctΔ92; KD= 21 ± 2 nM; Fig. 3b;
Table 1). Next, we determined the three-dimensional structure of
the NHE1ctΔ92:CN triple complex to a resolution of 1.9 Å (CN:
CNA1–370, CNB16–170; Supplementary Table 1). In addition to the
electron density observed for CN, strong electron density was
observed for NHE1 residues N681-A688 (LxVP motif) and D713-
S723 (PxIxIT motif) (Fig. 3a). The NHE1 LxVP and PxIxIT
motifs bind CN in the canonical LxVP and PxIxIT-binding
pockets, both of which are ~35 Å distal to the CN active site.
The interaction of NHE1 with the CN PxIxIT-binding pocket,
which buries 626Å2 of solvent accessible surface area (SASA), is
similar to that observed in other CN–PxIxIT complexes (Fig. 3c).
Namely, the NHE1 PxIxIT motif forms a β-strand that hydrogen
bonds with β14 of CNA, extending one of its central β-sheets.
Typically, the PxIxIT interaction is further stabilized by multiple
hydrophobic contacts between the two conserved I residues. A
comparison of the NHE1–PxIxIT interaction with CN to other
CN–PxIxIT complexes revealed that the hydrophobic interaction is
unique and non-optimal (Fig. 3d). Speciﬁcally, in the NHE1-CN
complex, both NHE1 PxIxIT residues T718 and D720 form
hydrogen bonds with CNA N330. This alters the NHE1 backbone
conformation (likely facilitated by the restricted Φ/Ψ space due to
NHE1 P721), causing the sidechain of I719 to project out of the
hydrophobic CNA PxIxIT-binding pocket (CNA M290, Y288,
I331). To conﬁrm this, we mutated the NHE1 PxIxIT motif to a
canonical, optimal sequence (PVIVIT), which bound CN ﬁve-fold
more tightly thanWT NHE1ctΔ92 (Supplementary Fig. 3A; Table 1).
This non-optimal hydrophobic interaction of NHE1 I719 with CN
explains the unusually weak binding of the NHE1 PxIxIT motif to
CN, as measured using ITC and co-IP experiments.
The interaction of NHE1 with CN at the LxVP-binding pocket,
which buries 560 Å2 of SASA, is essentially identical to those
observed between CN and other LxVP motifs21. The interaction
is dominated by NHE1 LxVP residues L684 and V686, which
bind CN in two deep hydrophobic pockets formed at the CNA/B
interface (Fig. 3e). Interestingly, and different to the interaction
observed between CN and the NFATc1-LxVPpeptide26, residues N-
terminal to the NHE1 LxVP motif also contribute to binding,
albeit in a slightly different manner. Speciﬁcally, NHE1 N682 (−2
relative to LxVP) forms a weak hydrogen-bond with CNB Q50,
while NHE1 N681 (−3) forms a hydrogen-bond with CNA K360.
This shows that residues ﬂanking LxVP motifs also contribute to
CN binding.
PxIxIT
Active site
815S771 T779 S785
LxVP
Calcineurin
S726
NHE1
Calmodulin
CHP1/2
Out
In
a
PxIxIT
S693 S723
b
Disordered distal tail
(NHE1ct)
680 815
LID
LxVP
NHE1ct
c 680
(CN: CNA/CNB)
Fig. 1 Two canonical docking motifs mediate the interaction of NHE1ct with CN. a Cartoon illustrating the major structural elements of NHE1, including the
C-terminal disordered distal tail (NHE1ct). The locations of the LxVP (dark orange) and PxIxIT (magenta) motifs and ERK2 phosphorylation sites (circles)
are highlighted. b Cartoon illustrating the major elements of CN, including binding sites for the LxVP (light orange) and PxIxIT (light pink) motifs and the
metals (spheres) bound at the active site. c Sequence conservation of the LxVP and PxIxIT motifs, the 27-residue linker including the RAR motif (see later)
and the ERK2-mediated phosphorylation sites in NHE1ct. Species abbreviations are deﬁned in the “Methods” section
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The motif-connecting linker dynamically interacts with CN.
Despite the observation that most of the NHE1 residues linking
the LxVP and PxIxIT motifs exhibited line broadening (Fig. 2a,
b), no electron density was detected for residues H689-E712
(Fig. 3a). Thus, these linker residues remain ﬂexible and engage in
a dynamic interaction with CN. This is further supported by the
ITC data for the NHE1ctATAP and NHE1ctAVATAA variants and
their corresponding peptides that report increases in afﬁnity from
interactions of linker residues with CN (Table 1). Because the
distance between the C-terminal residue of the LxVP motif and
the N-terminal residue of the PxIxIT motif is too short to allow
the linker to span the back side of CN, the structure also reveals
that the dynamic linker connects the motifs by spanning the
front, active-site containing side of CN.
Modeling potential paths that the linker may take to connect
the two motif binding pockets revealed a set of basic residues in
NHE1 (698RAR700) ideally positioned to electrostatically interact
with multiple acid patches (AP) on CN (AP1:E205/D211/D229;
AP2: E246; AP3: E237/D238; Fig. 3f). To determine if NHE1
residues 698RAR700 contribute to CN binding, we generated the
variant NHE1ctΔ92RARA (NHE1ctΔ92 698AAA700), which lacks the
ability to engage in charge:charge protein:protein interactions,
and then measured its afﬁnity for CN using ITC. While the
afﬁnity is unchanged (Supplementary Fig. 3B; Table 1), a change
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Fig. 2 NHE1 binding to CN. a Overlay of the 2D [1H,15N] HSQC spectra of 15N-labeled NHE1ct in the presence (black) and absence (red) of CN (1:1 ratio).
Peaks corresponding to residues from the docking motifs or linker region are labeled (red and black, respectively). b [1H,15N] HSQC peak intensity ratios for
spectra shown in a. ITC data for CN with c NHE1ct WT (n= 3), d NHE1ctATAP (n= 2), e NHE1ctAVATAA (n= 2), f *LxVP peptide (NHE1 Q678-P694) (n=
2), and g *PxIxIT peptide (NHE1 E709-P727) (n= 2); * for panels f and g indicates the use of a peptide. h PS120 ﬁbroblasts stably expressing NHE1 and
variants, with or without a 10 min pre-treatment with ionomycin to increase intracellular [Ca2+]i, were subjected to immunoprecipitation (IP) using anti-
CNA antibody (n= 4). IP and input were blotted for NHE1 and CN. P150 is shown as loading control. Quantiﬁcation of data from h is shown in
Supplementary Fig. 2. i Proximity ligation assay (PLA) of NHE1 and CN in MCF7 breast cancer cells (n= 3). PLA signal is seen in red, and cells were stained
for nucleus (DAPI) and F-actin. PLA was carried out using anti-NHE1 (NHE1–54) and anti-CNA (top panel) and only anti-NHE1 as a control (bottom panel).
j Quantiﬁcation of the results in i using ImageJ. ***Indicate a p-value of <0.001 compared to the control, unpaired Student’s t-test. Error bars represent
S.E.M. values. Source data are provided as a Source Data ﬁle
Table 1 Isothermal titration calorimetry (ITC)
measurements of NHE1ct with CN
NHE1cta KD (nM) ΔH (kcal
mol−1)
TΔS (kcal
mol−1)
NHE1ct (NHE1 I680-Q815)
NHE1ct WTb 59 ± 9 −12 ± 2 −2.5 ± 1.4
NHE1ct motif variants
NHE1ctAVATAA 2400 ± 500 −7.6 ± 0.7 0.9 ± 0.2
NHE1ctATAP 4800 ± 500 −4.5 ± 0.7 −2.8 ± 0.8
NHE1 motif peptides
PxIxIT (NHE1 E709-P727) 6500 ± 500 −2.9 ± 1.4 4.2 ± 1.5
LxVP (NHE1 Q678-P694) 4300 ± 500 −8.6 ± 1.0 −1.3 ± 1.1
Minimal NHE1 CN-binding domain
NHE1ctΔ92 (NHE1ct I680-
S723)
21 ± 2 −8.5 ± 0.4 2.0 ± 0.3
NHE1ctΔ92 (PVIVIT) 4.0 ± 0.4 −9 ± 2 2.7 ± 2.3
Charge neutral NHE1ct dynamic linker
NHE1ctΔ92RARA 21 ± 2 −12.2 ± 0.1 −1.7 ± 1.2
TxxP mutant
NHE1ct P782A 48 ± 2 −2.8 ± 0.1 7.2 ± 0.1
All measurement with n = 2 or 3
aWT NHE1ct and all NHE1ct variant measurements performed with WT CN (CNA1–370:CNB1–170)
bErrors (±) are S.D.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11391-7
4 NATURE COMMUNICATIONS |         (2019) 10:3489 | https://doi.org/10.1038/s41467-019-11391-7 | www.nature.com/naturecommunications
in TΔS indicated reduced ﬂexibility in the charge neutral
interaction; thus, NHE1 R698 and R700 likely mediate dynami-
cally important electrostatic interactions with CN.
To conﬁrm these results, we used NMR spectroscopy. An
overlay of the 2D [1H,15N] HSQC spectrum of 15N-labeled
NHE1ctΔ92RARA in the presence and absence of CN showed that
nearly all peaks broadened beyond detection (Supplementary
Fig. 4). This conﬁrms the ITC results of reduced ﬂexibly. We also
determined the 3D structure of the NHE1ctΔ92RARA:CN complex
to a resolution of 1.9 Å (Supplementary Fig. 5; Supplementary
Table 1). Electron density is observed for CN and for NHE1
residues I681-A688 (LxVP motif) and D713-S723 (PxIxIT motif)
but not for the linker; this shows that the intervening linker does
not form a single conformation that can be identiﬁed using X-ray
crystallography and highlights the importance of using comple-
mentary biophysical techniques for studying dynamic
interactions.
CN speciﬁcally dephosphorylates NHE1 pT779. Having estab-
lished that NHE1 binds CN via both a PxIxIT and LxVP motif,
we asked whether NHE1 is simply a CN scaffold or is additionally
a CN substrate. Recently, we used NMR-based phosphorylation
assays to show that the NHE1ct is phosphorylated by ERK2 at
multiple sites (pS693, pS723, pS726, pS771, pT779, pS785;11
Fig. 4a). These sites are phosphorylated similarly by other
MAPKs (p38α and JNK1; Supplementary Fig. 6). Here, we used
NMR spectroscopy to monitor CN-mediated dephosphorylation
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Fig. 3 The NHE1 CN-binding motifs are connected by a dynamic linker. a Crystal structure of NHE1ctΔ92:CN. NHE1 residues are shown as sticks in dark
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shown as spheres (Fe: brown, Zn: slate). Multiple modeled conformations of the linker are illustrated with dashed lines (L1–L4) reﬂecting the dynamic
nature of the linker. NHE1ctΔ92 sequence; residues modeled into electron density are underlined, with the LxVP and PxIxIT sequences colored as in
a; 698RAR700 highlighted in green. b ITC data for NHE1ctΔ92:CN binding (n= 2). c NHE1 PxIxIT (715PVITIDPA722; magenta) interactions with CNA (white).
NHE1 P715, I717, and I719 bind in three deep hydrophobic pockets of CNA. d Overlay of NHE1 residues 715PVITID720 with that of the 6PVIVIT11 peptide
structure (yellow, PDBID, 2P6B [http://dx.doi.org/10.2210/pdb2P6B/pdb]; CNA from both structures was superimposed). NHE1 I719 rotates out of the
pocket compared to the bound 6PVIVIT11 peptide. CNA N330 is shown as sticks. NHE1 residues T718 and D720 form hydrogen bonds with CNA N330.
e NHE1 LxVP (681NNYLTVP687; dark orange) interactions at the CNA/CNB (white/gray) interface. NHE1 N681 and N682 form hydrogen bonds with CNA
K360 and CNB Q50, respectively. fMultiple modeled conformations of the linker bound to CN. Linkers shown in mint (L1), blue (L2), light purple (L3), and
green (L4) dashed loops. NHE1 R698 and R700 side chains are shown as sticks while CNA is shown as surface. Acidic patches (AP1:E205/D211/D229;
AP2: E246; AP3: E237/D238) are highlighted in red
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of phosphorylated NHE1ct. Of these six ERK2 phosphorylated
residues, only pT779 was speciﬁcally and rapidly depho-
sphorylated by CN (Fig. 4a, b; Table 2, Supplementary Table 2).
To explore if phosphorylation of T779 impacts NHE1 function,
WT NHE1 and the variants NHE1 T779A (prevents phosphor-
ylation) and NHE1 T779D (mimics phosphorylation) were
expressed in PS120 cells that lack endogenous NHE activity. All
NHE1 variants localized to the plasma membrane similarly to
WT NHE1 (Fig. 4c, Supplementary Fig. 7) and expressed to
similar levels (Fig. 4d, e). To measure NHE1 activity, cells were
loaded with the pH-sensitive ﬂuorophore BCECF-AM, and
subjected to an NH4Cl prepulse-induced acidiﬁcation in the
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Fig. 4 NHE1 T779 is rapidly and speciﬁcally dephosphorylated by CN. a Overlay of extracts from the 2D [1H,15N] HSQC spectra of ERK2-phosphorylated
NHE1ct before (red), and after the addition of CN (black). Addition of CN resulted in disappearance of peaks for the phosphorylated state of T779 and
reappearance of peaks reporting on the unphosphorylated state of T779 (V777, dashed circle). The peaks corresponding to the ﬁve SP phosphorylation
sites were not affected. b Time course of in vitro NHE1ct dephosphorylation by CN following the peaks from the six ERK2 phosphorylated residues. Cartoon
of NHE1ct (colored as in Fig. 1c), with the symbols of the phosphorylation sites corresponding to the dephosphorylation time-course curves shown below.
c Top: Representative immunoﬂuorescence (IF) images of the six variant PS120 cell lines stained for NHE1 (red) and DAPI (blue) to evaluate NHE1
expression and localization. Images were taken at ×60 magniﬁcation on an Olympus Cell Vivo microscope. Scale bars represent 20 μm (n= 2). Bottom:
Representative line scans showing the membrane localization of each variant. (For overview images conﬁrming clonality and cell surface biotinylation to
conﬁrm membrane localization see Supplementary Fig. 7.) d Representative Western blot of the six variant PS120 cell lines blotted for NHE1. The lower
band corresponds to immature unglycosylated NHE1 and the upper band to glycosylated NHE1; p150 was used as loading control. e Total NHE1 expression
was quantiﬁed using ImageJ and normalized for each variant to the loading control and then to the expression of the WT cell line. One-way ANOVA with
Dunnet’s post-test (n= 5 biologically independent experiments for all cell lines except 779, where n= 3). f Representative traces of BCECF-AM
ﬂuorescence converted to pHi for the six variant PS120 cell lines showed over the time course of addition of Na+-free solution and Ringer solution. The
recovery rates as ΔpH*10–3*s−1 of each cell line are depicted in g. One-way ANOVA with Dunnet’s post-test. (The number of biologically independent
experiments were as follows: T779A: 6n; WT, ATAP, AVATAA: 5n; P120, ATA/AVATAA: 4n; 779D: 3n.) * and *** denotes p < 0.05 and p < 0.001,
respectively. Error bars represent S.E.M. values. Source data are provided as a Source Data ﬁle
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absence of HCO3−. Under these conditions, recovery from
acidiﬁcation represents the activity of the exogenously expressed
NHE1. As a control, untransfected PS120 cells showed no pHi
recovery (Fig. 4f, g). Cells expressing the NHE1 T779D
phosphomimetic mutant had a pHi recovery rate that was ≥3-
times faster than cells expressing WT NHE1. By comparison,
NHE1 T779A showed a non-signiﬁcant increase in pHi recovery
rate. Furthermore, cells expressing the NHE1ATAP/AVATAA
mutant also exhibited increased pHi recovery rate compared to
WT NHE1. Together, these results show that the interaction with
CN, and speciﬁcally the dephosphorylation of NHE1 pT779,
negatively regulates NHE1 activity, and conversely, that phos-
phorylation of T779 increases the transport activity of NHE1.
Speciﬁcity of CN for pT779 is not due to Thr preference.
Having established that NHE1 T779 is a functionally important
phosphorylation site and that its regulation by CN is essential for
NHE1 function in cells, we set out to identify the molecular
mechanisms by which CN speciﬁcally recognizes and depho-
sphorylates NHE1 pT779. The inability of CN to dephosphorylate
pS693, pS723, and pS726 is explained by their close proximity to
the NHE1 LxVP and PxIxIT motifs (Figs. 1c and 3a), which
sterically prevents them from reaching the CN active site. How-
ever, both NHE1 pS771 and pS785, along with pT779, are ≥50
residues C-terminal to the NHE1 PxIxIT motif. Because all three
residues can readily reach the CN active site, additional
mechanisms must be responsible for restricting CN activity to
only NHE1 pT779.
PPPs preferentially dephosphorylate Thr over Ser, although the
underlying molecular mechanism is unknown27. Thus, one
possibility for the preferred dephosphorylation of pT779 is that
it is a Thr (Fig. 5a). To test this, we repeated the depho-
sphorylation experiments using a NHE1ct T779S variant. As
expected, CN dephosphorylated pT779S more slowly than pT779
(WT) (Fig. 5b). However, the dephosphorylation of pT779S was
still faster than the rate measured for any other NHE1ct
phosphorylated Ser residues (pS693, pS723, pS726, pS771,
pS785; Fig. 4b; Table 2, Supplementary Table 2). To further
conﬁrm the speciﬁcity of CN for Thr, we also generated a NHE1ct
S785T variant. CN did dephosphorylate pS785T; however, the
rate of dephosphorylation was much slower than that observed
for pT779 (Fig. 5c; Table 2, Supplementary Table 2). Thus, while
these data conﬁrm the preference of CN for Thr over Ser residues,
generally, the enhanced dephosphorylation of pT779 speciﬁcally
is not solely explained by this preference.
The motifs differentially modulate NHE1 dephosphorylation.
To determine the role(s) of the PxIxIT and LxVP motifs for
dephosphorylation of NHE1ct, we repeated the NMR time course
experiments using the NHE1ctATAP, NHE1ctAVATAA, and
NHE1ctATAP/AVATAA variants (Fig. 5d; Table 2, Supplementary
Table 2). The data showed the following. First, abolishing the
NHE1 PxIxIT:CN interaction (NHE1ctAVATAA) reduced the
dephosphorylation rate of pT779 (no additional sites were
dephosphorylated). Second, abolishing the NHE1 LxVP:CN
interaction (NHE1ctATAP) increased the dephosphorylation rate
for pT779, accompanied by slow dephosphorylation of pS771 and
pS785 (Table 2, Supplementary Table 2). Third, depho-
sphorylation of NHE1ctATAP/AVATAA resembled that of NHE1c-
tATAP with additional slow dephosphorylation of pS693, pS723,
and pS726 (Table 2, Supplementary Table 2). Fourth, to test the
contribution of the LxVP interaction, we repeated the depho-
sphorylation of pT779 using only CNA, which lacks the LxVP-
binding pocket (this pocket is only present when CNB is bound to
CNA via CNA residues 348–370). Again, the dephosphorylation
rate of pT779 was signiﬁcantly faster (Fig. 5e; Table 2, Supple-
mentary Table 2). Finally, we tested the contribution from elec-
trostatics and thereby the dynamics of the 27-residue linker using
NHE1ctRARA (NHE1ct 698AAA700), which led to a 1.5-fold
increased rate of pT779 dephosphorylation (Supplementary
Fig. 8A; Table 2). This shows that the 27-residue linker directly
negatively inﬂuences the rate of pT779 dephosphorylation.
These dephosphorylation results are fully consistent with our
molecular data. First, loss of binding at the PxIxIT site (CN with
Table 2 Apparent in vitro dephosphorylation rates of NHE1 by CN
NHE1ct or CN variant Site Phosphosite sequencea kdephos (10−3 h−1)^
NHE1ct WT and variantsb
NHE1ct
NHE1ct WT pT779 771SPGTDDVFTPAPSDSPS787 98 ± 3
NHE1ct motif variants
NHE1ctAVATAA pT779 771SPGTDDVFTPAPSDSPS787 11 ± 3
NHE1ctATAP pT779 771SPGTDDVFTPAPSDSPS787 642 ± 28
NHE1ctAVATAA/ATAP pT779 771SPGTDDVFTPAPSDSPS787 811 ± 55
NHE1ct dynamic linker variant
NHE1ctRARAc pT779 771SPGTDDVFTPAPSDSPS787 199 ± 10
Role of Thr vs. Ser in CN-mediated dephosphorylation
NHE1ct T779S pT779S 771SPGTDDVFSPAPSDSPS787 1 ± 2
NHE1ct S785T pT779
pS785T
771SPGTDDVFTPAPSDTPS787
777VFTPAPSDTPSSQRIQ792
193 ± 5
35 ± 7
Role of TxxP motif in CN-mediated dephosphorylation
NHE1ct P782A pT779 771SPGTDDVFTPAASDSPS787 28 ± 3
NHE1ct S785T/S787A/S788P
785TPAP788
pT779
pS785T
771SPGTDDVFTPAPSDTPA787
777VFTPAPSDTPAPQRIQ792
102 ± 7
96 ± 7
CN variantsd
CNA pT779 771SPGTDDVFTPAPSDSPS787 347 ± 10
CNAAc pT779 771SPGTDDVFTPAPSDSPS787 60 ± 10
aSequence: dephosphorylated residue (underlined)
bAll reactions performed using CN and the NHE1ct constructs indicated
cReactions performed with a 20:1 (vs.100:1) NHE1ct:CN ratio and the rates normalized using wt-NHE1ct
dAll reactions performed using NHE1ct with the CN constructs indicated
^Apparent rates of dephosphorylation were extracted from global non-linear least-square ﬁts of disappearing peaks (dephosphorylation) to single exponentials in SigmaPlot. The standard errors (±) of
the estimated parameters were reported to represent conﬁdence intervals
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NHE1ctAVATAA) lead to an overall reduction in the dephosphoryla-
tion rate of pT779 without loss of speciﬁcity, most easily explained
by the increased distance between the substrate site (pT779) and the
closest docking site on CN for this variant, i.e. the LxVP motif. In
contrast, loss of binding at the LxVP site (CN with NHE1ctATAP or
NHE1ctATAP/AVATAA; NHE1ct with CNA) negated the unique
speciﬁcity for pT779. This effect most likely stems from an abolished
interaction between CN and the 27-residue linker that connects the
NHE1 LxVP and PxIxIT-binding motifs. As established, this linker
interacts in a dynamic manner with CN. To conﬁrm this model, we
repeated the dephosphorylation of NHE1ctATAP by CN in the
presence of a large excess of LxVP peptide (CN:NHE1ctATAP:
LxVPpeptide molar ratio of 1:100:100). Based on the respective
concentrations and afﬁnities, this should result in nearly 100%
occupancies of both the LxVP and PxIxIT-binding sites (by the
LxVPpeptide and NHE1ctATAP, respectively). Again, a much faster
dephosphorylation rate was observed (Fig. 5f; Table 2), further
supporting that the 27-residue linker connecting the LxVP and
PxIxIT sites restricts access to the CN active site and that anchoring
the linker via the LxVP CN pocket controls this speciﬁcity.
Our dephosphorylation data show that the presence of the
linker not only reduces the dephosphorylation rate of pT779 but
also increases the speciﬁcity of CN for only pT779. This is because
slow dephosphorylation of pS771 and pS785 is only observed in
the absence of linker-anchoring at the LxVP site (i.e. with
NHE1ctATAP). Considering the difference in co-localization, these
results are consistent with an observed increase in acidiﬁcation
recovery in NHE1 motif variants compared to WT NHE1 when
expressed in PS120 cells (Fig. 4f, g).
A TxxP motif is a preferred substrate for CN. While the NHE1
linker inﬂuences CN dephosphorylation speciﬁcity and rates, an
activity that requires the LxVP interaction, these interactions are
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k NHE1 NHE1ctΔ92:CNAA structure with the modeled pTPAP peptide from i, j. Source data are provided as a Source Data ﬁle
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not solely responsible for the observed speciﬁcity of CN for NHE1
pT779. We reasoned that residues surrounding T779 also play a
role. The only structural information describing interactions at
the CN active site is from the structure of CN bound to the CN
AID (481ERMP484)19. AID residue E481, which mimics a phos-
phorylated residue, binds at the active site, blocking substrate
access. The AID sequence has a proline residue in the i+ 3
position (P484). This is of interest because phosphorylated TxxP
motifs identiﬁed in CN regulators and substrates have been
hypothesized to bind directly at the CN active site28.
NHE1 T779 is also part of a TxxP motif (779TPAP782). This led
us to hypothesize that NHE1 P782 contributes to the speciﬁc
dephosphorylation of pT779 by CN. Using ITC, we showed that
the afﬁnity of the NHE1ctP782A variant for CN was unchanged
(Supplementary Fig. 3C; Table 1). In spite of the identical afﬁnity,
the dephosphorylation of pT779 was impaired in this variant
(Fig. 5g; Table 2), demonstrating the proline in the i+ 3 position
(P782) is essential for robust dephosphorylation. To conﬁrm the
role of the TxxP motif as a CN-speciﬁc substrate determinant, an
additional TxxP motif was introduced at a different NHE1ct site.
Speciﬁcally, the NHE1 S785 sequence was replaced with a TxxP
sequence (784DSPSSQR790 to DTPAPQR) and the dephosphor-
ylation analysis repeated (Fig. 5h). The dephosphorylation rates
for the Thr residues in both TPAP motifs (T779 and S785T, both
TxxP) were fast and similar (Table 2, Supplementary Table 2),
conﬁrming the role of the TxxP motif as a bona ﬁde substrate
determinant for CN.
Molecular basis for TxxP recognition. Next, we created a model
where we replaced the CN AID 481ERMP484 sequence with the
NHE1 779TPAP782 sequence (Fig. 5i). We speculated that NHE1
P782 likely binds in the same hydrophobic pocket as that used by
CN AID P484; namely, that created by CN H155 and Y159
(Fig. 5j). To test this, we generated the CNAA variant (CNA:
H155A/Y159A, CNB). CN and CNAA had identical melting
temperatures, conﬁrming the maintenance of overall structure
(Supplementary Table 3). We also measured CN activity using p-
nitrophenyl phosphate (pNPP; a small, general none-speciﬁc
substrate for CN) assays. Both CN and CNAA had identical Km
and kcat values, showing that catalysis is identical for both CN
variants (Supplementary Table 3). We then determined the
structure of the NHE1ctΔ92:CNAA complex (2.3 Å resolution;
Supplementary Fig. 5B; Supplementary Table 1). As expected,
electron density was observed for CNAA and for NHE1 residues
N682-A688 (LxVP motif) and D713-S723 (PxIxIT motif) (Sup-
plementary Fig. 5C). However, the NHE1ctΔ92:CNAA structure
had a much shallower H155A/Y159A Pro-binding pocket than
WT CN, while the remaining structure was unchanged (Fig. 5k,
Supplementary Fig. 5B). Indeed, comparing the buried surface
area of a modeled TPAP sequence for CN and CNAA showed the
NHE1 P782 pocket to be ~36% larger in CN. We then measured
the dephosphorylation rate of pT779 by CNAA, which decreased
by ~50% compared to that with WT CN (Supplementary Fig. 8B;
Table 2, Supplementary Table 2). This strongly supports the
conclusion that the NHE1 TxxP sequence interacts with CN in a
manner similar to the CN AID. Thus, the presence of a Pro at the
i+ 3 position (relative to pThr) enhances a substrate’s afﬁnity for
the CN active site by interacting with the H155/Y159 pocket.
Because these residues are not conserved between the family of
PPPs, the observed i+ 3 Pro selectivity is speciﬁc for CN (Sup-
plementary Fig. 5D).
Discussion
The balance between phosphorylation and dephosphorylation
controls cell signaling and cellular communication. Ser/Thr
kinases, the enzymes catalyzing phosphorylation, use protein:
protein interactions and substrate-speciﬁc recognition sequences
to identify their substrates. Conversely, the mode(s) of substrate
recognition for the PPP Ser/Thr protein phosphatase family (PP1,
PP2A, PP2B/3, PP4, PP5, PP6, and PP7) is not known. While it
has become clear that at least PP1, PP2A, PP2B, and PP4 utilize
protein:protein interactions for substrate binding24,26,29, it is still
unclear if and how these interactions direct substrate speciﬁcity
for single dephosphorylation sites, often 50 residues or more away
from the scaffolding motifs. Our lack of understanding of
molecular selectivity determinants in PPPs hampers bioinfor-
matics analysis to assign PPP:substrate pairs, thus impairing
progress in obtaining a systems biology understanding of
signaling.
One protein that is tightly regulated by both protein:protein
interactions and post-translational modiﬁcations is NHE1, an
evolutionarily conserved acid-extruding transporter serving as a
key regulator of cellular pHi in essentially all mammalian cells
studied4. Six NHE1ct residues are phosphorylated by ERK2, a
kinase that is often activated downstream of, or in parallel with,
increases in [Ca2+]i30,31. A previous report showed that an NHE1
T779A/S785A mutant exhibited a tendency for reduced NHE1
activation by sustained acidosis32. We show here that phos-
phorylation of T779 increases NHE1 activity and, in turn, pT779
is dephosphorylated by the Ca2+-activated phosphatase, CN. This
suggests the existence of a feedback mechanism, in which the
extent and duration of NHE1 activation by ERK are restricted by
its dephosphorylation following [Ca2+]i-induced CN activation.
As excessive NHE1 activation is associated with, e.g. uncontrolled
cell division and growth3, this intrinsic brake on its activity is
likely physiologically meaningful. In conjunction with previous
work showing that CN activity in vivo is regulated by NHE1-
dependent pHi changes16, this reveals the existence of a dynamic
complex of mutual regulatory interactions with the NHE1–CN
interaction at its core.
We show that the two canonical CN-speciﬁc SLiMs, a pre-
viously identiﬁed PxIxIT motif and a newly discovered LxVP
motif, contribute to NHE1 binding of CN. As observed for other
CN regulators and inhibitors, minor changes in these motifs lead
to signiﬁcant changes in interaction strength22,26. Interestingly,
mutation of both sites was insufﬁcient to abolish endogenous CN
binding to full-length NHE1 in a cellular context—likely reﬂect-
ing the known, extensive scaffolding properties of NHE1, which
forms dynamic, multiprotein complexes at the plasma mem-
brane33. Further, in NHE1, the LxVP sequence (684LTVP687) is
not only an LxVP motif but also functions as a D-domain/Kinase
Interaction Motif (KIM) that is essential for ERK2 binding and
scaffolding. The use of an overlapping sequence ensures that
ERK2 and CN binding to NHE1 is mutually exclusive.
We also discovered that the LxVP motif is essential for
directing the speciﬁcity of CN for NHE1 pT779. However, it does
so in an unanticipated and indirect manner. Namely, NHE1
forms a critical anchor for a 27-residue linker that dynamically
associates with CN across its front surface. In doing so, it reduces
access to the CN active site, which in turn, reduces the overall
speed of dephosphorylation. Simultaneously, this increases the
speciﬁcity towards a single phosphorylated residue, pT779. While
it has been known for more than 30 years that CN prefers pThr
over pSer substrates27, we discovered that this preference alone
does not fully explain selectivity for pT779. Rather, a proline in
the i+ 3 position (relative to pThr, TxxP) makes a speciﬁc and
unique interaction with a CN surface binding pocket formed by
CN residues H155 and Y159. These residues are not conserved in
any other PPP, i.e., the speciﬁc dephosphorylation of the TxxP
motif is unique to CN. Taken together this shows that CN uses a
combination of mechanisms, including a dynamic interaction
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with a 27-residue linker that restricts substrate access to a unique
interaction pocket adjacent to the catalytic site leading to a pre-
ference for TxxP motifs, to achieve exquisite speciﬁcity towards a
single Thr in NHE1, resulting in rapid and speciﬁc depho-
sphorylation of this residue, hence limiting the duration of NHE1
activation following its ERK-induced phosphorylation. This is
furthermore a remarkable example on how disordered linkers in
complexes have direct functional relevance, in this case acting as a
substrate speciﬁcity ﬁlter for CN.
While this is clearly a complex mechanism, a number of
aspects will be true for other CN substrates. Current data show
that the CN interaction SLiMs (PxIxIT and LxVP) have variable
roles in substrate recruitment and only minor roles for speci-
ﬁcity. In contrast, the i+ 3 proline-binding pocket in CN allows
for speciﬁc recruitment to the active site. Thus, identiﬁcation of
the PxIxIT and/or LxVP motifs, together with an [S/T]xxP site
provides a powerful computational strategy for identifying and
testing currently unrecognized CN substrates. To support this
notion, we used our previously developed CNcon database (48
experimentally conﬁrmed CN interaction proteins)26. Thirty-
three CNcon members were previously shown to contain one or
more LxVP sites (11 of which have been experimentally ver-
iﬁed). Here, we extended the analysis and searched for [ST]xxP
sequences in IDRs. We discovered that 32 CNcon members
have conﬁrmed/predicted LxVP and [ST]xxP sites in an IDR,
with 50% of the [ST]xxP sites positioned 10–35 residues from
the LxVP site (C-terminal) and ~90% within 10–100 residues
(≥9 residues are required to bridge the CN LxVP-binding
pocket to the CN active site). The number of [ST]xxP sites in a
single substrate is highly variable (1–42). Further, when
examined together, the identiﬁed [ST]xxP sites have an equal
distribution of Ser/Thr residues. Although not every identiﬁed
[ST]xxP site is likely a bona ﬁde CN substrate, our data suggests
that many will be. Thus, depending on the phosphorylating
kinase and distinct spatial, temporal, and cellular inputs, mul-
tiple different [S/T]xxP sites within a single substrate may
barcode time-dependent CN activity.
Together, this study not only highlights the importance of
T779 phosphorylation for NHE1 function and regulation, but
provides the most comprehensive molecular understanding of
how CN recruits a speciﬁc substrate. First, our data suggest the
existence of a feedback mechanism in which the extent and
duration of NHE1 activation by ERK are restricted by its
dephosphorylation following [Ca2+]i-induced CN activation.
Second, our data identify an active site recognition sequence for
CN, TxxP. These results are in striking contrast to the recruit-
ment of substrates to PP1, which uses steric exclusion and multi-
domain scaffolding. Thus, this speciﬁc amino acid sequence
([S/T]xxP) can now be leveraged—together with PxIxIT and/or
LxVP motifs—to identify and test speciﬁc CN substrates sites.
Because of the importance of CN activity for a diversity of bio-
logical functions, our discoveries not only provide key insights
into NHE1 function and regulation, but also provide fundamental
advances for establishing a systems-level understanding of CN
signaling networks.
Methods
Sequence alignments. ClustalW was used to create all sequence alignments. The
following species are used in Fig. 1c: Amphiuma tridactylum (atNHE1; sala-
mander), Xenopus laevis (xlNHE1; clawed frog), Mus musculus (mmNHE1;
mouse), Rattus norvegicus (rnNHE1; rat), Cricetulus griseus (cgNHE1; Chinese
hamster); Sus scrofa (ssNHE1; pig), Bos taurus (btNHE1; cow), Homo sapiens
(hNHE1; human), Oryctolagus cuniculus (ocNHE1; rabbit), Gallus gallus (ggNHE1;
chicken), Takifugu rubripes (trNHE1; Japanese pufferﬁsh), Pleuronectes americanus
(paNHE1; winter ﬂounder), Platichthys ﬂesus (pfNHE1; European ﬂounder);
Oncorhynchus mykiss (omβNHE1; rainbow trout), and Cyprinus carpio
(ccNHE1; carp).
Protein expression and puriﬁcation. DNA coding the human NHE1 I680-Q815
(NHE1ct) was subcloned into a pET-11a expression vector11. DNA coding the
human NHE1ctΔ92 was subcloned into a pET-M30-MBP vector, which encodes an
N-terminal His6-tag followed by maltose-binding protein (MBP) and a TEV
(tobacco etch virus) protease cleavage site. The following human NHE1 (see also
Supplementary Fig. 1) and human CN variants were generated using the Quik-
change (Agilent) site-directed mutagenesis kit: NHE1/NHE1ctATAP (L684A,
V686A), NHE1/NHE1ctAVATAA (P715A, I717A, I719A, D720A), NHE1/NHE1c-
tATAP/AVATAA, (L684A, V686A, P715A, I717A, I719A, D720A), NHE1 T779A,
NHE1 T779D, NHE1ct T779S, NHE1ct S785T, NHE1ct P782A, NHE1ct S785-
TPAP (S785T, S787A, S788P), NHE1ct/NHE1ctRARA (R698A, R700A),
NHE1ctΔ92PVIVIT, CNAA (alpha isoform, subunit A: M1-A391, H155A, Y159A,
subunit B: 1–170), CNA/CNB (alpha isoform, subunit A: M1-N370, H155A,
Y159A, subunit B: 16–170), CNA (alpha isoform: H27-D348; two C-terminal ASP
residues were added for increased CNA solubility).
For protein expression, NHE1ct and CN were expressed as described11,21.
Brieﬂy, proteins were expressed in E. coli BL21 (DE3) cells (Agilent). Cell cultures
were grown at 37 °C under vigorous shaking (250 rpm) to an OD600 of 0.7. Cells
were cooled at 4 °C for one hour, while the shaker temperature was lowered to
18 °C. Expression was induced by addition of 1 mM IPTG, and the cultures were
grown for an additional 18 h at 18 °C (250 rpm). The cells were harvested by
centrifugation (6000× g, 15 min, 4 °C) and stored at −80 °C. NHE1ctΔ92 was
expressed in E. coli BL21 (DE3) CodonPlus-RIL cells (Agilent). Cells were grown in
Luria Broth in the presence of selective antibiotics at 37 °C up to OD600 of 0.6–0.8,
and expression was induced by the addition of 1 mM isopropyl-β-D-1-
thiogalactopyranoside (IPTG). NHE1ctΔ92 was expressed for 4 h at 37 °C and CN
expressed for 18 h at 18 °C prior to harvesting by centrifugation at 6000 × g. Cell
pellets were stored at −80 °C until puriﬁcation. For NMR measurements,
expression of uniformly 15N-labeled and/or 13C-labeled NHE1 was achieved by
growing cells in M9 minimal media containing 1 g/L 15NH4Cl and/or 4 g/L [13C]-
D-glucose (CIL or Isotec) as the sole nitrogen and carbon sources, respectively.
CN and NHE1ct were puriﬁed as described11,21 or carried out as follows. For all
proteins, cell pellets were lysed in lysis buffer (20 mM Tris–HCl pH 8.0, 500 mM
NaCl, 5 mM Imidazole, 0.1% Triton X-100) containing EDTA-free protease
inhibitor cocktail (Roche) using high-pressure homogenization (Avestin). The
lysate was clariﬁed by centrifugation at 45,000 × g for 60 min at 4 °C. The
supernatant was ﬁltered through a 0.22 μm ﬁlter before loading onto a 5 ml
HisTrap HP column (GE Healthcare) equilibrated in Buffer A (50 mM Tris–HCl
pH 8.0, 500 mM NaCl, and 5 mM imidazole). Bound proteins were washed with
Buffer A and were eluted using a linear gradient of Buffer B (50 mM Tris–HCl pH
8.0, 500 mM NaCl, 500 mM imidazole). Peak fractions were pooled and dialyzed
overnight at 4 °C (50 mM Tris–HCl pH 8.0, 500 mM NaCl, 0.5 mM TCEP) with
TEV protease to cleave the His6-tag. The next day, the protein was incubated with
Ni2+-NTA resin (GE Healthcare) to remove TEV and the cleaved His-tag. Cleaved
NHE1ct or NHE1ctΔ92 was incubated at 80 °C and centrifuged at 14,000 × g for
10 min, the supernatant was puriﬁed using size-exclusion chromatography (SEC;
Superdex 75 26/60 [GE Healthcare]) equilibrated in SEC buffer (20 mM Tris–HCl
pH 7.5, 100 mM NaCl, 1 mM CaCl2, and 0.5 mM TCEP) and concentrated to 1–2
mg/ml prior to storage at −80 °C. CN was puriﬁed identically, except the cleaved
product was further puriﬁed by anion exchange chromatography (HiTrap QHP;
low salt loading buffer: 20 mM Tris–HCl pH 7.5, 50 mM NaCl, 1 mM CaCl2, and
0.5 mM TCEP; high salt elution buffer: 20 mM Tris–HCl pH 7.5, 800 mM NaCl,
1 mM CaCl2, and 0.5 mM TCEP) prior to SEC (Superdex 75 26/60 [GE
Healthcare], equilibrated in SEC buffer; 20 mM Tris–HCl pH 7.5, 100 mM NaCl, 1
mM CaCl2, and 0.5 mM TCEP).
To form NHE1ct:CN complexes, CN (CNA1–370, CNB16–170) was puriﬁed as
described above except fractions containing CN after the anion exchange
chromatography step were combined and incubated with a three-fold molar excess
of NHE1ctΔ92 or NHE1ctΔ92RARA. The complex was then concentrated and puriﬁed
using SEC (Superdex 75 26/60) pre-equilibrated with the crystallization buffer (20
mM Tris–HCl pH 7.5, 100 mM NaCl, 1 mM CaCl2 and 0.5 mM TCEP).
NMR spectroscopy. NMR data were acquired at 25 °C on a Varian INOVA 800
MHz (1H) spectrometer with a room temperature probe or a Bruker AVANCE/
NEO 600 or 750MHz (1H) spectrometer equipped with cryogenic probes. Free
induction decays were transformed and visualized in NMRPipe34 or Topspin 4.05
(Bruker BioSpin) and the spectra analyzed using both the CCPN Analysis soft-
ware35 and CARA36 (http://www.cara.nmr.ch). Interaction and time course
experiments were recorded on Varian 800MHz (1H) NMR spectrometers with a
5 mm triple resonance probe with a Z-ﬁeld gradient or a Bruker NEO 600MHz
(1H) NMR spectrometer with a 5 mm TCI-active HCN z-gradient cryoprobe at
5 °C (interaction) or 25 °C (time-course experiments). Chemical shift referencing
was relative to 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) and spectra were
zero ﬁlled, Fourier transformed and baseline corrected in NMRDraw34 or Topspin
4.05 (Bruker BioSpin) and analyzed in CCPN Analysis35. For the phosphorylation
experiments using different MAPKs, NMR samples of 400 μL of 200 μM 15N-
labeled NHE1ct were prepared in PBS buffer pH 7.0, 5 mM ATP, 10 mM MgCl2,
0.01% (w/v) NaN3, 0.5 mM DSS, 5 mM DTT, 10% (v/v) 99.96% D2O. 2D [1H,15N]
HSQC spectra were recorded before and after incubation with the active
kinases (purchased from proteinkinase.de) for 48 h at 25 °C (1 µg of active ERK2,
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386 pmol/(µg*min); 2.7 µg of active p38α, 150 pmol/(µg*min); 2 µg of active JNK1,
514 pmol/(µg*min)). For the dephosphorylation experiments, a 400 μL sample of
200 µM 15N-labeled NHE1ct (WT and variants), phosphorylated by active ERK2 at
all six consensus sites, was prepared in PBS buffer pH 7.2 supplemented with
10 mM MgCl2, 0.5 mM CaCl2, 5 mM DTT, 0.5 mM DSS, 5–10% (v/v) 99.96% D2O.
A reference 2D [1H,15N] HSQC spectrum was recorded before addition of phos-
phatase. Dephosphorylation was initiated by addition of 2 µM unlabeled active
CNA or CN resulting in a molar excess of NHE1ct:CN of 100:1. For the CNAA and
NHE1ctRARA variants, a 550 μL sample of 100 μM 15N-labeled NHE1ct, phos-
phorylated by active ERK237 at all six consensus sites, was prepared in 20 mM
HEPES pH 6.8, 100 mM NaCl, 1 mM CaCl2, 0.5 mM TCEP, 10 mM MgCl2, 10%
D2O. A reference 2D [1H,15N] HSQC spectrum was recorded before addition of
phosphatase. Dephosphorylation was started by addition of 5 µM unlabeled active
CN resulting in a molar excess of NHE1ct:CN of 20:1. Dephosphorylation was
monitored by extraction of intensities from a series of 2D [1H,15N] HSQC spectra.
Apparent rates of dephosphorylation were extracted from global non-linear least-
square ﬁts of disappearing phosphorylated peaks and/or reporting neighbor peaks
to single exponentials in SigmaPlot.
ITC measurements. Protein concentration of CN (CNA M1-N370, CNB M1-
V170) and NHE1 variants were measured in triplicate using the Pierce 660 assay
(Thermo Fisher). All protein samples were equilibrated in 20 mM Tris–HCl pH
7.5, 100 mM NaCl, 1 mM CaCl2, and 0.5 mM TCEP. NHE1 or variants (30–50 µM,
syringe) was titrated into CN (5–10 µM, cell) using a 250 or 300 s interval at 25 °C.
Twenty-ﬁve injections were delivered during each experiment over a period of 20 s
(VP-ITC microcalorimeter) or 10 s (Afﬁnity-ITC microcalorimeter) and the
solution in the sample cell was stirred at 307 rpm (VP-ITC microcalorimeter) or
125–200 rpm (Afﬁnity-ITC microcalorimeter) to ensure rapid mixing. All data was
analyzed using NITPIC and ﬁtted to a single site-binding model using SED-
PHAT38; ﬁgures generated using GUSSI39.
Proximity ligation assays. Proximity ligation assay was carried out using a
Duolink II Detection Reagents Red kit (Sigma Aldrich). WT MCF7 cells were
seeded on coverslips the day before assaying (MCF-7 cells were a kind gift from
Lone Ronnov-Jessen [University of Copenhagen, Denmark]). Cells were washed in
ice-cold PBS, ﬁxed in 4% PFA for 30 min on ice, and washed in PBS. Cells were
quenched using 0.1 M glycine for 15 min followed by permeabilization in 0.5%
Triton X-100 for 15 min. Cells were subsequently washed in Duolink II Buffer A
and blocked using O-link-blocking solution for 30 min. Cells were incubated with
the primary antibodies (NHE1: XB-17, 1:100 (gift from Mark Musch, University of
Chicago); CN: Millipore-Sigma, #C1956, 1:200) of interest diluted in Duolink II
antibody diluent for 60 min in a humidity chamber at 37 °C, and then incubated
with PLA probes diluted 1:5 in Duolink II Antibody Diluent buffer at 37 °C for
60 min. Coverslips were washed in Duolink II Buffer A and incubated with ligase
diluted 1:40 in 1x Duolink II ligation solution for 30 min at 37 °C, followed by wash
in Duolink II Buffer A. Subsequently, coverslips were incubated with a polymerase
diluted 1:80 in 1x Duolink II ampliﬁcation solution for 100 min at 37 °C. After
ampliﬁcation, coverslips were washed in Duolink Buffer A, incubated with phal-
loidin488 for 1 h, and treated with DAPI to stain nuclei. Finally, coverslips were
washed in Duolink Buffer A and MQ, mounted on object glass with mounting
buffer, and sealed with nail polish. Imaging was carried out with an Olympus BX-
61 epiﬂuorescence microscope using cellSens Dimensions V1.6 software. Images
were taken as z-stacks and z-projection images were created. Further image pro-
cessing and quantiﬁcation were carried out in ImageJ40. PLA signal was quantiﬁed
using particle analysis in Image J for a minimum of 100 cells, for both control
(using only anti-CN primary antibody; NHE1: XB-17, 1:100 (gift from Mark
Musch, University of Chicago); CN: Millipore-Sigma, #C1956, 1:200) and NHE1-
CN PLA signal. Furthermore, z-projection images were deconvoluted using the
cellSens Dimension V1.6 software for high-resolution qualitative images.
Co-Immunoprecipitation. Immunoprecipitation (IP) was carried out for fully
conﬂuent PS120 cells, expressing WT41, variant NHE1 or empty vector (PS120 cells
were generated in the laboratory of Dr. Jacques Pouyssegur [University of Nice,
France] and were a kind gift from Prof. Laurent Counillon [University of Nice
Sophia Antipolis, France]). Prior to IP, cells were subjected to a 10 min incubation
in physiological saline (Ringer solution, 135 mM salt) in the absence or presence of
5 µM ionomycin to increase cellular [Ca2+]. Cells were washed with PBS and lysed
in pre-heated IGEPAL lysis buffer (1% (v/v) IGEPAL CA-630, 1 mM NaF, 3 mM
Na3VO4, EDTA-free CompleteTM protease inhibitor, 50 mM Tris pH 7.4, and 140
mM NaCl), detached using a rubber policeman and incubated on ice for 30 min.
Preparation of lysates and determination of protein contents was done as described
for immunoblotting. 2 mg protein for each IP were incubated with primary anti-
bodies against CN and NHE1, or IgG control (1 µg antibody per mg lysate) for
30 min at 4 °C with gentle rolling. 50 µl (1.5 mg) pre-washed (2 × 10 min in lysis
buffer, 4 °C) Dynabeads Protein G (Invitrogen) were added to each sample, fol-
lowed by incubation for 30 min at 4 °C with gentle rotation. Beads were pelleted by
magnetic rack, and dynabeads with bound protein were washed 5 × 5min in 500 μL
lysis buffer, boiled for 5 min at 95 °C with 80 μL sample buffer, mixed thoroughly,
and incubated on ice for 30 min to ensure full elution. Proteins were separated
using SDS–PAGE and analyzed by Western blotting as above. Input samples were
analyzed in parallel.
Immunoblotting. Cells were grown to ~80% conﬂuence in 10 cm Petri dishes,
washed in ice-cold PBS, lysed in boiling lysis buffer (1% SDS, 10 mM Tris–HCl, pH
7.5), sonicated, and centrifuged to clear debris. Identical amounts of protein
(15–25 µg/well) diluted in NuPAGE LDS sample buffer (Lifetech Technologies)
were boiled for 5 min, separated on NuPAGE 10% bis–tris gels, and transferred to
nitrocellulose membranes using the Novex gel system (Novex, San Diego, CA).
Membranes were stained with Ponceau S to conﬁrm equal loading, blocked for 1 h
at 37 °C in blocking buffer (120 mM NaCl, 10 mM Tris–HCl, 5% nonfat dry milk),
and incubated with the relevant primary antibodies in blocking buffer overnight at
4 °C. After washing in TBST (TBS+ 0.1% Tween-20), membranes were incubated
with HRP-conjugated secondary antibodies (1:2000, Sigma), washed in TBST, and
visualized using BCIP/NBT. For quantiﬁcations, blots were scanned, and band
intensities quantiﬁed using Un-Scan-IT Graph Digitizer software (Silk Scientiﬁc).
Protein bands were normalized to those of the loading control (p150) from the
same gel to eliminate gel-to-gel differences. For immunoprecipitation samples,
protein bands were normalized to the input, from the same gel. Uncropped and
unprocessed scans of the blots are provided in the Source Data ﬁle. Primers and
recombinant DNA used in this study are summarized in Supplementary Table 4.
Immunoﬂuorescence analysis of NHE1 and CN. For immunoﬂuorescence
experiments, cells were grown on 12mm round glass coverslips until ~80% con-
ﬂuency and ﬁxed in 2% MeOH (15 min on ice). Coverslips were washed three times
for 5 min in PBS, permeabilized for 15 min (0.5% Triton X-100 in TBS), blocked
for 30 min (5% BSA in TBST), and incubated with primary antibody against NHE1
(antibody details see below) in TBST+ 1% BSA at RT for 1.5 h. Coverslips were
again washed in TBST+ 1% BSA, and incubated with AlexaFluor568 conjugated
secondary antibody (1:600 in TBS+ 1% BSA) for 1.5 h. Finally, coverslips were
incubated with DAPI (1:1000) for 5 min to stain nuclei, washed in TBST, and
mounted in N-propyl-galleate mounting medium (2% w/v in PBS/glycerol). Cells
were visualized using the ×60/1.35 NA objective of an Olympus Bx63 epi-
ﬂuorescence microscope. Image adjustments were carried out using ImageJ soft-
ware. Line scans were performed using the ColorProﬁler ImageJ software plugin.
Crystallization, data collection, and structure determination. The NHE1ctΔ92:
CN complex (and variants) was concentrated to 8–10 mg/ml in 10 mM Tris–HCl
pH 7.5, 100 mM NaCl, 1 mM CaCl2, 0.5 mM TCEP. Initial crystallization trials
using sitting drop vapor diffusion yielded needle-like crystals in 40% (v/v) PEG
600, 100 mM CHES/sodium hydroxide pH 9.5 at RT. Optimization was performed
using the initial crystal hits as seed stock for seeding. The ﬁnal crystals were
obtained from seeding in 40% (v/v) PEG 600, 100 mM CHES/sodium hydroxide
pH 9.5, 0.2 M MgCl2. Crystals were cryoprotected using a 15-s soak in mother
liquor and immediately ﬂash frozen in liquid nitrogen. Data were collected at SSRL
(beamline 12–2; NHE1ctΔ92:CN) or the University of Arizona (Bruker liquid
Gallium MetalJet X-ray Diffractometer with a Photon II CPAD detector;
NHE1ctΔ92RARA:CN and NHE1ctΔ92:CNAA). Data were processed using either
AutoXDS42,43, or SAINT/XPREP (Bruker AXS Inc., Madison, 2004). All three
structures were phased using molecular replacement (PHASER as implemented in
Phenix44), using a CN heterodimer molecule (CNA/B; PDB ID 5SVE26), as the
search model. A solution was obtained in space group C2221; clear difference
electron density for the PxIxIT and LxVP motifs was visible in the initial maps. The
initial models of the complex were built without NHE1 using AutoBuild, followed
by iterative rounds of reﬁnement in PHENIX and manual building using Coot45.
The NHE1 coordinates were then modeled, followed by additional rounds of
reﬁnement and model building. The percentage of the Ramachandran favored/
allowed residues for the NHE1ctΔ92:CN, NHE1ctΔ92RARA:CN, and NHE1ctΔ92:
CNAA structures are 97.7/2.1, 97.2/2.8, and 96.2/3.8, respectively. Data collection
and reﬁnement details are provided in Supplementary Table 1. Molecular ﬁgures
were generated using Pymol46. Linker residues that connect the NHE1 LxVP and
PxIxIT motifs were modeled using Coot.
Protein stability measurements. Protein stability measurements report on the
melting temperature of the protein (in 20 mM Tris–HCl pH 7.5, 100 mM NaCl,
1 mM CaCl2, and 0.5 mM TCEP) under investigation and were performed on a
Tycho NT.6 (Nanotemper) using standard capillaries (10 µl) using a 30 °C/min
ramp (from 35 to 95 °C) and evaluated using the Tycho NT.6 software version
1.1.5.668.
pNPP activity assay. The activities of freshly prepared CN and CNAA were
measured in assay buffer (20 mM Tris–HCl pH 7.5, 100 mM NaCl, 1 mM CaCl2,
1 mM MnCl2, 0.5 mM TCEP) containing varying concentrations of p-nitrophenyl
phosphate (pNPP; 0–8000 µM). Enzymes (0.5 µM) were incubated with substrate at
30 °C for 20 min. The reaction was stopped using 0.5 M sodium phosphate and the
absorbance measured at 405 nm using a plate reader (BioTek). Measured absor-
bance from blanks that contained substrate but no protein was subtracted from all
measurements. The rate of dephosphorylation of pNPP was analyzed using the
molar extinction coefﬁcient for pNPP (18,000 M−1 cm−1) and an optical path
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length of 0.3 cm (96-well plates). Km and Vmax were determined by ﬁtting to the
Michaelis–Menten equation, y= Vmax*x/(Km+ x); kcat was extracted using y=
Et*kcat*x/(Km+ x) (Sigma Plot 13). The catalytic efﬁciency was obtained as kcat/Km.
All experiments were carried out in triplicate.
Bioinformatics. The CNcon database was used for screening for the TxxP in other
CN substrates26. ScanProsite was used to identify LxVP sites using [NQDESRTH]-
[YTDFILV]Lx[VPL]X as deﬁnition, which is based on the experimental 3D
NFATc1LxVP:CN complex structure and experimentally conﬁrmed LxVP motifs.
Additionally, disorder prediction via IUPRED (IUPRED ≥0.4)47 was used to ensure
that identiﬁed πɸLxVP SLiMs are in IDRs. ScanProsite was further used to identify
TxxP motifs for proteins in the CNcon database with an LxVP site using [S/T]xxP
as the search deﬁnition. [S/T]xxP sites were also ﬁltered for IDR behavior using
different IDP predictors including IUPred. To identify the distance between C-
terminal LxVP and [S/T]xxP sites, a minimum cut-off of 9 residues was used, as
this distance is sufﬁcient to span the distance between the CN LxVP-binding
pocket and the CN active site.
Measurements of pHi. Measurements of pHi were performed using the ammo-
nium pre-pulse technique48. Brieﬂy, 7*104–10*104 PS120 WT-expressing or variant
NHE1-expressing cells were seeded in 24-well plates 24 h prior to the experiment,
then loaded with 2′,7′-bis-(2-carboxyethyl)-5-(and-6)-carboxyﬂuorescein acetox-
ymethylester (BCECF-AM, 1.6 µM) for 30 min at 37 °C. Cells were washed in
Ringer solution (in mM, 130 NaCl, 3 KCl, 20 Hepes, 1 MgCl2, 0.5 CaCl2, 10 NaOH
pH 7.4) twice, then bathed in Ringer again and placed in a FluoStar Optima plate
reader (37 °C). Emission was measured at 520 nm and excitation at 485 nm. After
baseline measurement (10 min) in Ringer, acidiﬁcation was induced by washout of
20 mM NH4Cl after 5 min exposure. Na+-free solution (in mM, 135 NMDGCl, 3
KCl, 20 Hepes, 1 MgCl2, 0.5 CaCl2, pH 7.4) was applied for 1.5 min then the
recovery was measured in Ringer for 10 min. Calibration was performed using the
high-K+/nigericin technique (in mM, 140 KCl, 10 Hepes, 1 MgCl2, 0.5 CaCl2,
50 μM nigericin, pH 7.4) and an eight-point calibration curve. Maximal acid-
iﬁcation did not differ statistically between cell lines, hence recovery rate was
calculated as the slope of the initial linear part of the recovery curve.
Cell surface biotinylation. To determine the surface fraction of all NHE1 variants,
cells were incubated for 30 min at 4 °C with freshly made EZ-Link Sulfo-NHS-SS-
Biotin (Life Technologies, #21331) diluted in PBS, followed by washing in cold
quenching buffer (0.1 M glycine in PBS). Cells were lysed in cold RIPA buffer (150
mM NaCl, 50 mM Tris–HCl pH 7.5, 0.1% SDS, 0.5% sodium deoxycholate, 1%
Igepal CA630, and CompleteTM mini protease inhibitor). Samples were centrifuged
(15 min, 16,000 × g, 4 °C), and the supernatant was adjusted to equal amounts of
protein (DC assay, BioRad). A fraction of the supernatant was dissolved in 4x LDS
sample buffer and saved as total lysate fraction. Remaining supernatant was
incubated with prewashed streptavidine beads (Sigma-Aldrich, #S1638) for 2 h at
4 °C. Samples were washed in cold RIPA buffer, dissolved in 2x LDS sample buffer
and heated for 5 min at 95 °C. Beads were pelleted (4 min, 2000 × g, 4 °C), the
supernatant saved as the pull-down fraction and samples were processed for
Western blotting.
Antibodies. Catalog numbers and dilutions used for WB, Western blot; IF,
immunoﬂuorescence analysis; IP, immunoprecipitation; PLA, proximity ligation
assay: NHE1-54 (Santa Cruz Biotechnology, #sc-136239): WB and IF: 1:100; CNA
(Cell Signaling Technology, #5530, #5532): WB 1:200; XB-17 (Mark Musch
[University of Chicago]): IF, PLA 1:100; p150 (BD Bioscience, BD610473): WB
1:1000; NHE1 4e9 (Millipore-Sigma, #MAB3140); CNA (Millipore-Sigma,
#C1956): PLA 1:2000; CNA (Millipore-Sigma, #C1956) and IgG isotype ctrl (Cell
Signaling Technology, #CS2729) for IP: all 1 µg/mg total protein; HRP-conjugated
secondary antibodies (Agilent-Dako #P0447 (mouse) and #P0448 (rabbit)): WB
1:4000; Alexa ﬂuor-conjugated secondary antibodies (ThermoFisher #A10037
(mouse) and #A10042 (rabbit)): IF 1:600.
Quantiﬁcation and statistical analysis. ITC measurements were repeated
between 2 and 4 times; reported values are the average and standard deviation for
the replicated measurements. Sigma Plot 12.5/13 was used for the statistical ana-
lysis of activity assays. For cell biological data, all data are shown as representative
images or as mean measurements with standard error of means (SEM) error bars,
and represent at least three independent experiments unless stated otherwise. A
two-tailed unpaired Student's t-test was applied to test for statistically signiﬁcant
differences between two groups. When comparing more than two groups one-way
analysis of variance (ANOVA) with Dunnett’s multiple comparison post-test was
used, except in Supplementary Fig. 2, where two-way ANOVA was applied. *, **,
*** and **** denotes p < 0.05, p < 0.01, p < 0.001, and p < 0.0001, respectively.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All NMR chemical shifts have been deposited in the BioMagResBank with the accession
codes BMRB 26755 and BMRB 27812. Atomic coordinates and structure factors have
been deposited in the Protein Data Bank with the accession codes 6NUC, 6NUF and
6NUU. The source data underlying Figs. 2c–j, 3b, 4b–g, 5b–h and Supplementary
Figs. 3a–c, 7, 8a, b and Supplementary Tables 2 and 3 are provided as a Source Data ﬁle.
All other data supporting the ﬁndings of this study are available from the corresponding
authors on reasonable request.
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